Toll Free: 1-888-928-9744
Published: Dec, 2016 | Pages:
39 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Polyphor Ltd - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Polyphor Ltd - Product Pipeline Review - 2016', provides an overview of the Polyphor Ltd's pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Polyphor Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Polyphor Ltd - The report provides overview of Polyphor Ltd including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Polyphor Ltd's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Polyphor Ltd's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons To Buy - Evaluate Polyphor Ltd's strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Polyphor Ltd - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Polyphor Ltd's pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Polyphor Ltd Snapshot 6 Polyphor Ltd Overview 6 Key Facts 6 Polyphor Ltd - Research and Development Overview 7 Key Therapeutic Areas 7 Polyphor Ltd - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Pipeline Products - Partnered Products 12 Partnered Products/Combination Treatment Modalities 13 Polyphor Ltd - Pipeline Products Glance 14 Polyphor Ltd - Clinical Stage Pipeline Products 14 Phase II Products/Combination Treatment Modalities 14 Phase I Products/Combination Treatment Modalities 15 Polyphor Ltd - Early Stage Pipeline Products 16 Preclinical Products/Combination Treatment Modalities 16 Discovery Products/Combination Treatment Modalities 17 Polyphor Ltd - Drug Profiles 18 balixafortide - Drug Profile 18 Product Description 18 Mechanism Of Action 18 R&D Progress 18 POL-5551 - Drug Profile 19 Product Description 19 Mechanism Of Action 19 R&D Progress 19 POL-6014 - Drug Profile 20 Product Description 20 Mechanism Of Action 20 R&D Progress 20 POL-6926 - Drug Profile 22 Product Description 22 Mechanism Of Action 22 R&D Progress 22 POL-7001 - Drug Profile 23 Product Description 23 Mechanism Of Action 23 R&D Progress 23 POL-7080 - Drug Profile 24 Product Description 24 Mechanism Of Action 24 R&D Progress 24 POL-7080 Follow-On - Drug Profile 26 Product Description 26 Mechanism Of Action 26 R&D Progress 26 Small Molecules for Unspecified Indication - Drug Profile 27 Product Description 27 Mechanism Of Action 27 R&D Progress 27 Synthetic Peptides for Unspecified Indication - Drug Profile 28 Product Description 28 Mechanism Of Action 28 R&D Progress 28 Synthetic Peptides to Agonize FPR1/2 for Immunology and Infectious Disease - Drug Profile 29 Product Description 29 Mechanism Of Action 29 R&D Progress 29 Synthetic Peptides to Antagonize FPR1/2 for Immunology and Infectious Disease - Drug Profile 30 Product Description 30 Mechanism Of Action 30 R&D Progress 30 Polyphor Ltd - Pipeline Analysis 31 Polyphor Ltd - Pipeline Products by Target 31 Polyphor Ltd - Pipeline Products by Route of Administration 32 Polyphor Ltd - Pipeline Products by Molecule Type 33 Polyphor Ltd - Pipeline Products by Mechanism of Action 34 Polyphor Ltd - Dormant Projects 35 Polyphor Ltd - Discontinued Pipeline Products 36 Discontinued Pipeline Product Profiles 36 POL-7080 36 Polyphor Ltd - Locations And Subsidiaries 37 Head Office 37 Appendix 38 Methodology 38 Coverage 38 Secondary Research 38 Primary Research 38 Expert Panel Validation 38 Contact Us 38 Disclaimer 39
List of Tables Polyphor Ltd, Key Facts 6 Polyphor Ltd - Pipeline by Indication, 2016 9 Polyphor Ltd - Pipeline by Stage of Development, 2016 10 Polyphor Ltd - Monotherapy Products in Pipeline, 2016 11 Polyphor Ltd - Partnered Products in Pipeline, 2016 12 Polyphor Ltd - Partnered Products/ Combination Treatment Modalities, 2016 13 Polyphor Ltd - Phase II, 2016 14 Polyphor Ltd - Phase I, 2016 15 Polyphor Ltd - Preclinical, 2016 16 Polyphor Ltd - Discovery, 2016 17 Polyphor Ltd - Pipeline by Target, 2016 31 Polyphor Ltd - Pipeline by Route of Administration, 2016 32 Polyphor Ltd - Pipeline by Molecule Type, 2016 33 Polyphor Ltd - Pipeline Products by Mechanism of Action, 2016 34 Polyphor Ltd - Dormant Developmental Projects,2016 35 Polyphor Ltd - Discontinued Pipeline Products, 2016 36
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.